Government fund of funds
Development institute of the Russian Federation

News

Venture funds continue to grow upward in 2017
13.12.2017
According to Firrma's annual activity rating of Russian venture funds, the strategic partners of which are RVC and EY, 2017 saw three times as many established venture capital funds (11) compared to the previous year (4).
American biotechnology company OncoTartis Inc., which is developing a new class of antitumor drugs, raised $ 6 million from two investors. The funds will be used to conduct Phase I of clinical trials for OT-82, a drug for resistant forms of acute leukemia.
The Russian venture capital market's key results of 2017 were presented on November 30, 2017 at the IV annual Forum "Ecosystem of Innovations" organized by RVC. The experts summed up the year's results, outlined current problems and trends in the venture capital market development.
RVC, Roscosmos and VEB Innovations announced establishment of a venture fund in form of Investment Partnership Agreement. The agreement of intent was signed by Alexander Povalko, the CEO of RVC, Anton Zhiganov, executive director for business development and commercialization at Roskosmos and Kirill Bulatov, CEO of VEB Innovations LLC.
Alexey Basov was appointed Deputy General Director and Investment Director of RVC. Alexey will be in charge for the implementation of company's strategy in the field of investment policy, programs and projects.
For the pilot implementation of the projects of the National Technological Initiative, a working group will be established in the Novgorod Oblast, including representatives of the NTI Project Office, the Administration and public authorities of the Novgorod Oblast, companies participating in the road maps of the NTI markets as well as individual technological entrepreneurs.


1 2 3 4 5 ... 22 Next
News for 2018: January

Search by name:

Search by date:

Select date in calendar
Select date in calendar
Venue: